Cargando…
Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
Medications to treat major depressive disorder (MDD) are not equally effective across patients. Given that neural response to rewards is altered in MDD and given that reward-related circuitry is modulated by dopamine and serotonin, we examined, for the first time, whether reward-related neural activ...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047617/ https://www.ncbi.nlm.nih.gov/pubmed/31462766 http://dx.doi.org/10.1038/s41380-019-0490-5 |
_version_ | 1783502159196717056 |
---|---|
author | Greenberg, Tsafrir Fournier, Jay Stiffler, Richelle Chase, Henry W. Almeida, Jorge R. Aslam, Haris Deckersbach, Thilo Cooper, Crystal Toups, Marisa Carmody, Tom Kurian, Benji Peltier, Scott Adams, Phillip McInnis, Melvin G. Oquendo, Maria A. Fava, Maurizio Parsey, Ramin McGrath, Patrick J. Weissman, Myrna Trivedi, Madhukar Phillips, Mary L. |
author_facet | Greenberg, Tsafrir Fournier, Jay Stiffler, Richelle Chase, Henry W. Almeida, Jorge R. Aslam, Haris Deckersbach, Thilo Cooper, Crystal Toups, Marisa Carmody, Tom Kurian, Benji Peltier, Scott Adams, Phillip McInnis, Melvin G. Oquendo, Maria A. Fava, Maurizio Parsey, Ramin McGrath, Patrick J. Weissman, Myrna Trivedi, Madhukar Phillips, Mary L. |
author_sort | Greenberg, Tsafrir |
collection | PubMed |
description | Medications to treat major depressive disorder (MDD) are not equally effective across patients. Given that neural response to rewards is altered in MDD and given that reward-related circuitry is modulated by dopamine and serotonin, we examined, for the first time, whether reward-related neural activity moderated response to sertraline, an antidepressant medication that targets these neurotransmitters. 222 unmedicated adults with MDD randomized to receive sertraline (n=110) or placebo (n=112) in the EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care) study completed demographic and clinical assessments, and pre-treatment functional magnetic resonance imaging while performing a reward task. We tested whether an index of reward system function in the ventral striatum (VS), a key reward circuitry region, moderated differential response to sertraline versus placebo, assessed with the Hamilton Rating Scale for Depression over 8 weeks. We observed a significant moderation effect of the reward index, reflecting the temporal dynamics of VS activity, on Week-8 depression levels (Fs≥9.67,ps≤0.002). Specifically, VS responses that were abnormal with respect to predictions from reinforcement learning theory were associated with lower Week-8 depression symptoms in the sertraline versus placebo arms. Thus, a more abnormal pattern of pre-treatment VS dynamic response to reward expectancy (expected outcome value) and prediction error (difference between expected and actual outcome), likely reflecting serotonergic and dopaminergic deficits, was associated with better response to sertraline than placebo. Pre-treatment measures of reward-related VS activity may serve as objective neural markers to advance efforts to personalize interventions by guiding individual-level choice of antidepressant treatment. TRIAL REGISTRATION: NCT01407094; http://clinicaltrials.gov/show/NCT01407094 |
format | Online Article Text |
id | pubmed-7047617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
record_format | MEDLINE/PubMed |
spelling | pubmed-70476172020-06-21 Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals Greenberg, Tsafrir Fournier, Jay Stiffler, Richelle Chase, Henry W. Almeida, Jorge R. Aslam, Haris Deckersbach, Thilo Cooper, Crystal Toups, Marisa Carmody, Tom Kurian, Benji Peltier, Scott Adams, Phillip McInnis, Melvin G. Oquendo, Maria A. Fava, Maurizio Parsey, Ramin McGrath, Patrick J. Weissman, Myrna Trivedi, Madhukar Phillips, Mary L. Mol Psychiatry Article Medications to treat major depressive disorder (MDD) are not equally effective across patients. Given that neural response to rewards is altered in MDD and given that reward-related circuitry is modulated by dopamine and serotonin, we examined, for the first time, whether reward-related neural activity moderated response to sertraline, an antidepressant medication that targets these neurotransmitters. 222 unmedicated adults with MDD randomized to receive sertraline (n=110) or placebo (n=112) in the EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care) study completed demographic and clinical assessments, and pre-treatment functional magnetic resonance imaging while performing a reward task. We tested whether an index of reward system function in the ventral striatum (VS), a key reward circuitry region, moderated differential response to sertraline versus placebo, assessed with the Hamilton Rating Scale for Depression over 8 weeks. We observed a significant moderation effect of the reward index, reflecting the temporal dynamics of VS activity, on Week-8 depression levels (Fs≥9.67,ps≤0.002). Specifically, VS responses that were abnormal with respect to predictions from reinforcement learning theory were associated with lower Week-8 depression symptoms in the sertraline versus placebo arms. Thus, a more abnormal pattern of pre-treatment VS dynamic response to reward expectancy (expected outcome value) and prediction error (difference between expected and actual outcome), likely reflecting serotonergic and dopaminergic deficits, was associated with better response to sertraline than placebo. Pre-treatment measures of reward-related VS activity may serve as objective neural markers to advance efforts to personalize interventions by guiding individual-level choice of antidepressant treatment. TRIAL REGISTRATION: NCT01407094; http://clinicaltrials.gov/show/NCT01407094 2019-08-28 2020-07 /pmc/articles/PMC7047617/ /pubmed/31462766 http://dx.doi.org/10.1038/s41380-019-0490-5 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Greenberg, Tsafrir Fournier, Jay Stiffler, Richelle Chase, Henry W. Almeida, Jorge R. Aslam, Haris Deckersbach, Thilo Cooper, Crystal Toups, Marisa Carmody, Tom Kurian, Benji Peltier, Scott Adams, Phillip McInnis, Melvin G. Oquendo, Maria A. Fava, Maurizio Parsey, Ramin McGrath, Patrick J. Weissman, Myrna Trivedi, Madhukar Phillips, Mary L. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals |
title | Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals |
title_full | Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals |
title_fullStr | Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals |
title_full_unstemmed | Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals |
title_short | Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals |
title_sort | reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047617/ https://www.ncbi.nlm.nih.gov/pubmed/31462766 http://dx.doi.org/10.1038/s41380-019-0490-5 |
work_keys_str_mv | AT greenbergtsafrir rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT fournierjay rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT stifflerrichelle rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT chasehenryw rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT almeidajorger rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT aslamharis rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT deckersbachthilo rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT coopercrystal rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT toupsmarisa rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT carmodytom rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT kurianbenji rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT peltierscott rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT adamsphillip rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT mcinnismelving rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT oquendomariaa rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT favamaurizio rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT parseyramin rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT mcgrathpatrickj rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT weissmanmyrna rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT trivedimadhukar rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals AT phillipsmaryl rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals |